412 related articles for article (PubMed ID: 29950615)
1. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway.
Guo DK; Zhu Y; Sun HY; Xu XY; Zhang S; Hao ZB; Wang GH; Mu CC; Ren HG
Acta Pharmacol Sin; 2019 Jan; 40(1):26-34. PubMed ID: 29950615
[TBL] [Abstract][Full Text] [Related]
2. Circadian clock protein Rev-erbα regulates neuroinflammation.
Griffin P; Dimitry JM; Sheehan PW; Lananna BV; Guo C; Robinette ML; Hayes ME; Cedeño MR; Nadarajah CJ; Ezerskiy LA; Colonna M; Zhang J; Bauer AQ; Burris TP; Musiek ES
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5102-5107. PubMed ID: 30792350
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Rev-erbα Agonist SR9011 on the Immune Response and Cell Metabolism of Microglia.
Wolff SEC; Wang XL; Jiao H; Sun J; Kalsbeek A; Yi CX; Gao Y
Front Immunol; 2020; 11():550145. PubMed ID: 33101272
[TBL] [Abstract][Full Text] [Related]
4. Activation of Rev-erbα attenuates lipopolysaccharide-induced inflammatory reactions in human endometrial stroma cells via suppressing TLR4-regulated NF-κB activation.
Zhao W; Cui L; Huang X; Wang S; Li D; Li L; Sun Y; Du M
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):908-914. PubMed ID: 31411318
[TBL] [Abstract][Full Text] [Related]
5. Rev-erbα can regulate the NF-κB/NALP3 pathway to modulate lipopolysaccharide-induced acute lung injury and inflammation.
Yu D; Fang X; Xu Y; Xiao H; Huang T; Zhang Y; Ge Y; Li Y; Zong L; Gao J
Int Immunopharmacol; 2019 Aug; 73():312-320. PubMed ID: 31129418
[TBL] [Abstract][Full Text] [Related]
6. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model.
Yue J; He J; Wei Y; Shen K; Wu K; Yang X; Liu S; Zhang C; Yang H
J Neuroinflammation; 2020 Jan; 17(1):43. PubMed ID: 32005256
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activation of rev-erbα suppresses LPS-induced macrophage M1 polarization and prevents pregnancy loss.
Cui L; Xu F; Wang S; Li X; Lin H; Ding Y; Du M
BMC Immunol; 2021 Aug; 22(1):57. PubMed ID: 34399700
[TBL] [Abstract][Full Text] [Related]
9. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation.
Kang CH; Jayasooriya RG; Dilshara MG; Choi YH; Jeong YK; Kim ND; Kim GY
Food Chem Toxicol; 2012 Dec; 50(12):4270-6. PubMed ID: 22974838
[TBL] [Abstract][Full Text] [Related]
10. Rev-erbα Inhibits Proliferation and Promotes Apoptosis of Preadipocytes through the Agonist GSK4112.
Chu G; Zhou X; Hu Y; Shi S; Yang G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547330
[TBL] [Abstract][Full Text] [Related]
11. Tripartite-motif protein 21 knockdown extenuates LPS-triggered neurotoxicity by inhibiting microglial M1 polarization via suppressing NF-κB-mediated NLRP3 inflammasome activation.
Xiao T; Wan J; Qu H; Li Y
Arch Biochem Biophys; 2021 Jul; 706():108918. PubMed ID: 33992596
[TBL] [Abstract][Full Text] [Related]
12. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
Yuan X; Dong D; Li Z; Wu B
Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
[TBL] [Abstract][Full Text] [Related]
13. REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice.
Shao R; Yang Y; Fan K; Wu X; Jiang R; Tang L; Li L; Shen Y; Liu G; Zhang L
Int J Med Sci; 2021; 18(16):3831-3838. PubMed ID: 34790059
[TBL] [Abstract][Full Text] [Related]
14. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
[TBL] [Abstract][Full Text] [Related]
15. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
[TBL] [Abstract][Full Text] [Related]
16. Rev-erbα regulates circadian rhythms and StAR expression in rat granulosa cells as identified by the agonist GSK4112.
Chen H; Chu G; Zhao L; Yamauchi N; Shigeyoshi Y; Hashimoto S; Hattori MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):374-9. PubMed ID: 22425774
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.
Morioka N; Kodama K; Tomori M; Yoshikawa K; Saeki M; Nakamura Y; Zhang FF; Hisaoka-Nakashima K; Nakata Y
Brain Behav Immun; 2019 May; 78():116-130. PubMed ID: 30682503
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor and clock gene REV-ERBα regulates cigarette smoke-induced lung inflammation.
Sundar IK; Rashid K; Sellix MT; Rahman I
Biochem Biophys Res Commun; 2017 Dec; 493(4):1390-1395. PubMed ID: 28974420
[TBL] [Abstract][Full Text] [Related]
19. A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.
Sato S; Sakurai T; Ogasawara J; Takahashi M; Izawa T; Imaizumi K; Taniguchi N; Ohno H; Kizaki T
J Immunol; 2014 Jan; 192(1):407-17. PubMed ID: 24307731
[TBL] [Abstract][Full Text] [Related]
20. L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-κB inhibition and Nrf2 pathway activation.
Chen J; Yin W; Tu Y; Wang S; Yang X; Chen Q; Zhang X; Han Y; Pi R
Eur J Pharmacol; 2017 Jul; 806():1-9. PubMed ID: 28320516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
